A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Clinical trial NCT06562985 · COMPLETED

Trial details

NCT number: NCT06562985
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Venous and Arterial Thrombotic and Thromboembolic Events Healthy Volunteers

Start date: 2024-09-18
Primary completion: 2025-01-06
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.